Moreover, we observed a reduced expression of HLA class II molecules (CD74, HLA-DRA, HLA-DRB1, HLA-DMA), which might affect the number and function of CD4+ T lymphocytes in the tumor microenvironment [47] (Fig. 3J). This evidence concerns the gene CD74 and neoplasm.